Kristof Szent-Ivanyi
Business Development Director Global Bulk Sales
GlaxoSmithKline 24 Shepherds Close
Hurley, Berkshire, NONE SL6 5LY
United Kingdom
Email: krszentivanyi@aol.com Type of Business: Executive Management Expertise: Business Development, Alliance Management, Operational Management Marketing Area: International Education/Degrees: M SC Process Engineering, Bsc Foreign Trade - University of Budapest Affiliations: A multilingual, influential and innovative senior director with a wealth of experience in delivering inspired Third Party Partnering Alliance Management solutions to business issues across a broad breadth of international markets. A charismatic and empathetic communicator and leader, able to motivate and inspire diverse teams to achieve even the most challenging goals. Favorite Publication: Financial Times Hobbies/Personal Interests: Kristof enjoys souring in a glider into the clouds, taking pictures of people in any environment - town or seaside, outdoor events or restaurants.Like to portrait people how they really behave. Family: Married Biography: KEY ACHIEVEMENTS Formulation and execution of GSK’s global bulk sales business development plan as the head of the function. Built a high achieving B2B sales structure on the combination of business development managers and agencies to reach the quickest market penetration with selected Alliance Solutions for Third Parties globally. Extensively worked with European, US, Chinese and Indian companies, developed a wide network and learned their culture. Annualised sales with underlying profit of £3 m reached already in the first years and selected factory utilisation increased by 20%. Led several in licensing programme on third party supply side. This required close liaison with subsidiary management and the formulation of an agreed, consistent and robust valuation model and the agreement of this with the different internal stakeholders. Negotiated the deals with third parties and managed the due diligence process. The most profitable deals where I led the third party supply side was the Arixtra and Fraxiparine deal which generated more than US$ 560 m sales at a reasonably high profit margin. Formation and empowerment of the wholesale team to negotiate with hospitals and pharmacies. This involved the introduction and development of hospital tender skills. As a result 85% of the participated hospital tenders were in favor of the company. Trade relations were significantly improved and double-digit growth in profitable sales achieved. Developed strategic procurement and business plan linking mission, goals, strategies, and tactics to business level for outsourcing pharmaceutical products. The newly formulated outsourcing business strategy implementation, and the highly motivated team delivered £15 m savings in three years, underlying margins improved and working capital requirements reduced by £10m. Facilitated a change in behavior of a mainly national team with EMAE procurement responsibility to adapt a multicultural approach for efficient operations i
Click here to see a full listing of premiere members.

